CYBREX TOBRAMYCIN— 510(k) K802668

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K802668 for CYBREX TOBRAMYCIN, Substantially Equivalent on 1980-11-24. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code LCR
Device class: Class 2
Regulation: 21 CFR 862.3900
Advisory panel: Clinical Toxicology
Date received: 1980-10-27
Decision date: 1980-11-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LCR

K060998 — QMS TOBRAMYCIN2006-07-21
K974029 — ACS TOBRAMYCIN1998-02-12
K962818 — TOBRAMYCIN FLEX REAGENT CARTRIDGE1996-09-13
K952568 — BECKMAN ARRAY TOBRAMYCIN (TOB) REAGENT1995-08-08
K911940 — OPUS(R) TOBRAMYCIN1991-07-01

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.